DB16328InvestigationalVaccines
Seviprotimut-L is under investigation in clinical trial NCT01546571 (Study of a Melanoma Vaccine in Stage Iib, Iic, and III Melanoma Patients).
- Also known as
- Human polyvalent shedded antigen vaccine · Seviprotimut L
- Code names
- POL-103A
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Seviprotimut-L, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account